Central Pacific Bank Trust Division Has $706,000 Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Central Pacific Bank Trust Division boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,200 shares of the company’s stock after buying an additional 200 shares during the quarter. Central Pacific Bank Trust Division’s holdings in Henry Schein were worth $706,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of HSIC. Cromwell Holdings LLC boosted its holdings in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the period. Studio Investment Management LLC lifted its position in Henry Schein by 3.8% during the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock worth $341,000 after acquiring an additional 172 shares during the last quarter. Simplify Asset Management Inc. boosted its holdings in shares of Henry Schein by 5.0% during the second quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after acquiring an additional 175 shares during the period. Huntington National Bank grew its position in shares of Henry Schein by 16.8% in the third quarter. Huntington National Bank now owns 1,515 shares of the company’s stock valued at $110,000 after purchasing an additional 218 shares during the last quarter. Finally, Deroy & Devereaux Private Investment Counsel Inc. increased its stake in shares of Henry Schein by 0.7% during the third quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 47,055 shares of the company’s stock worth $3,430,000 after purchasing an additional 325 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Up 0.8 %

NASDAQ HSIC opened at $69.09 on Friday. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The business’s fifty day moving average is $72.09 and its 200 day moving average is $70.28. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.61 billion, a price-to-earnings ratio of 28.43, a price-to-earnings-growth ratio of 2.30 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter last year, the firm earned $1.32 earnings per share. The company’s revenue for the quarter was up .4% on a year-over-year basis. As a group, sell-side analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on HSIC shares. Evercore ISI upped their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Barrington Research reiterated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. Finally, StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Seven investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $78.89.

Insider Transactions at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.